🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian GLP-1 coverage — 12 month update Page 6

Canadian GLP-1 coverage — 12 month update

Dr.SleepRoch Tue, Dec 17, 2024 at 4:46 AM 52 replies 2,746 viewsPage 6 of 11
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Dec 21, 2024 at 9:37 AM#26
Dr.MetabolicMD said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Dec 21, 2024 at 11:37 AM
20 18emily_PDX, Dr.SleepRoch, laura_annarbor and 17 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Dec 21, 2024 at 5:24 PM#27

Adding the numbers, since they settle part of this. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

21 19tom_AK, josh_phd_bmore, roxy_nash and 18 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Dec 22, 2024 at 1:11 AM#28

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Dec 22, 2024 at 5:11 AM
22 20GraceAZ_72, carl_compliance, DanielChem_CHI and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Dec 22, 2024 at 8:58 AM#29
TirzTom said:
One practical note: write down what you did and when, before you need it.

Pushing back on TirzTom here. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

23 21RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 20 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Dec 22, 2024 at 4:45 PM#30

Closing the loop on my own question.

Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.

45 18roxy_nash, tony_orlando, Dr.NephBHM_UK and 42 others
Reply Quote Save Share Report
14567811

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register